Last year, synthetic biologist George Church and a team at Harvard’s Wyss Institute combined three different gene therapies related to cellular decay into a single compound to see if it might reverse obesity and diabetes while also improving kidney and heart function. Remarkably, the technique seemed to work—in mice.